1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. Summary
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  11:35 2022-08-12 am EDT
0.0900 CHF   +49.50%
08/08IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
08/08IGEA PHARMA N : to get SIX further approval to the 2021 annual report disclosure
PU
08/02IGEA Pharma Suspends Trading Amid Delayed FY21 Annual Report
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

IGEA Pharma N : Note of the Board

06/15/2022 | 05:43pm EDT
Note of the Board
15 June 2022

The Board notices that the drafts of the Annual Report and the Annual Accounts for the financial year 2021 will unfortunately not be available in time for the upcoming AGM and therefore these documents as such cannot be approved and adopted, as the case may be, by the general meeting.

Given this situation, items 2. and 4. of the agenda should be read, and will be dealt with and explained by and at the meeting as the proposal to extend the period in which the annual accounts, accompanied by an auditor's statement, the annual report and additional information, should be made available, for a period of another five months, due to special circumstances (voting item). Any voting instructions as received on items 2 and 4 of the agenda for the AGM, will be dealt with and explained accordingly. The Board will do its utmost to have such documents for the financial year 2021 made available as soon as possible, and convene an extraordinary general meeting (EGM) to the best of its ability within a reasonable time period in order to have such documents approved and adopted, as the case may be, by the general meeting.

Disclaimer

IGEA Pharma NV published this content on 15 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 June 2022 21:42:03 UTC.


© Publicnow 2022
All news about IGEA PHARMA N.V.
08/08IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
08/08IGEA PHARMA N : to get SIX further approval to the 2021 annual report disclosure
PU
08/02IGEA Pharma Suspends Trading Amid Delayed FY21 Annual Report
MT
07/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
07/12IGEA Pharma Close to Finalizing $6 Million Investment Deal For Cannabidiol Extraction F..
MT
07/12IGEA PHARMA N.V. : Igea pharma has announced that lmh - an industrial holding company - ha..
EQ
06/26IGEA PHARMA N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15IGEA PHARMA N : Note of the Board
PU
06/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
06/08Igea Pharma Secures $6 Million Funds To Complete Cannabidiol Extraction Facility
MT
More news
Financials
Sales 2020 0,08 M - -
Net income 2020 -1,13 M - -
Net Debt 2020 0,03 M - -
P/E ratio 2020 -11,0x
Yield 2020 -
Capitalization 20,3 M 21,5 M -
EV / Sales 2019 14 046x
EV / Sales 2020 171x
Nbr of Employees 2
Free-Float 30,4%
Chart IGEA PHARMA N.V.
Duration : Period :
IGEA Pharma N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 0,06
Average target price
Spread / Average Target -
Managers and Directors
Vicenzo Moccia Chairman-Management Board
Sector and Competitors
1st jan.Capi. (M$)
IGEA PHARMA N.V.-69.44%22
BIOMÉRIEUX-15.25%12 925
DIASORIN S.P.A.-16.21%7 835
LANTHEUS HOLDINGS, INC.188.47%5 720
10X GENOMICS, INC.-67.56%5 504
NATERA, INC.-42.62%5 196